Pembrolizumab Efficacy in Metastatic Colon Cancer Case Report

Colorectal cancer is the third most commonly diagnosed cancer and second leading cause of cancer related death in the world Chemotherapy has been shown to be a more effective treatment for colorectal cancer over the past two decades and additionally survival rates have begun to increase further with the introduction of targeted monoclonal antibodies